Phase 2 Study of KD025 Shows Encouraging Clinical Response in Patients with Graft-versus-host Disease
News
Treatment with KD025 is safe and effectively reduces the manifestations of graft-versus-host disease in patients receiving steroids for the condition, or whose condition worsened while on steroids, Kadmon Holdings announced. Those findings ... Read more